93 results
6-K
EX-99.2
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
and the Rights Agent may require payment of a sum sufficient to cover any stamp or other Tax or charge that is imposed in connection with any such registration … state and local income Tax purposes, to treat (i) Milestone Payments with respect to the CVRs received with respect to the Scheme Shares and Company
6-K
EX-99.1
AMYT
Amryt Pharma Plc
3 Apr 23
High Court of Justice of England and Wales Sanctions Scheme of Arrangement
9:00am
initiatives and changes in tax laws; market volatility; and other risks and uncertainties affecting Amryt, including those described from time to time
6-K
EX-99.7
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
before interest, tax, depreciation, amortisation and share based compensation expenses. To supplement Amryt's financial results presented in accordance … of contingent consideration
Non-cash contingent value rights (loss)/gain
Net finance expense – other
Loss on ordinary activities before taxation
Tax (charge
6-K
EX-99.5
AMYT
Amryt Pharma Plc
4 Aug 22
Results of Annual General Meeting
7:38am
compensation expenses ($2.9M).
3 EBITDA is earnings before interest, tax, depreciation, amortisation and share based compensation expenses. To supplement … activities before taxation
Tax (charge)/credit on loss on ordinary activities
Loss for the period attributable to the equity holders of the Company
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
5:06pm
information contained in this prospectus, and may also contain information about any material U.S. federal income tax and/or UK tax considerations … the date of the general meeting.
A share buy-back by a company of its shares will give rise to UK stamp duty reserve tax and stamp duty at the rate of 0.5
424B4
7zhr1 td00nee4ech
20 May 22
Prospectus supplement with pricing info
4:58pm
424B4
s7tyso
20 May 22
Prospectus supplement with pricing info
4:57pm
F-3
p864a q20d7f
11 May 22
Shelf registration (foreign)
5:22pm
POS AM
6vvf 2avzujieu5vk
11 May 22
Prospectus update (post-effective amendment)
5:20pm
POS AM
zu103ehthr87ocmx2t
11 May 22
Prospectus update (post-effective amendment)
5:19pm
6-K
EX-99.1
qpjsla9
11 May 22
Current report (foreign)
4:30pm
424B3
p8dd7x bfdbu6s
4 May 22
Prospectus supplement
8:35am
424B3
oya2zu
4 May 22
Prospectus supplement
7:45am
6-K
EX-99.1
qgwo 4o0dcyno1g48eg
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am